title: Ondansetron prevents refractory and severe methotrexate-induced nausea in rheumatoid arthritis.
authors.forename: R
authors.initials: R
authors.lastname: Blanco
authors.forename: M A
authors.initials: MA
authors.lastname: González-Gay
authors.forename: C
authors.initials: C
authors.lastname: García-Porrúa
authors.forename: D
authors.initials: D
authors.lastname: Ibañez
authors.forename: M J
authors.initials: MJ
authors.lastname: García-Pais
authors.forename: A
authors.initials: A
authors.lastname: Sánchez-Andrade
authors.forename: M
authors.initials: M
authors.lastname: Vázquez-Caruncho
mesh_terms: D000932:Antiemetics / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000009:adverse effects*; D009325:Nausea / Q000139:chemically induced / Q000188:drug therapy*; D017294:Ondansetron / Q000627:therapeutic use*; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D000932:Antiemetics; D018501:Antirheumatic Agents; D017294:Ondansetron; D008727:Methotrexate